Advanced search
Publication Cover
Current Opinion on Therapeutic Patents Volume 2, 1992 - Issue 6
Journal homepage
16
Views
0
CrossRef citations to date
0
Altmetric
CNS Agents

Overview: Alzheimer's Disease: Current Developments, Diagnostic Approaches and Possible Therapeutic Interventions

Iradj Hajimohammadreza Institute of Psychiatry, Department of Neuroscience, De Crespigny Park, Denmark Hill, London SE5 8AF, UK; Institute of Psychiatry, Department of Neurology, De Crespigny Park, Denmark Hill London, SE5 8AF, UK
&
Michael J Brammer Institute of Psychiatry, Department of Neuroscience, De Crespigny Park, Denmark Hill, London SE5 8AF, UK
Pages 899-906 | Published online: 02 Mar 2011

References to Primary Literature

  • Abraham CR, Selkoe DJ, Potter Immunochemical identification of the serine protease inhibitor, α1-antichymotropsin in the brain amyloid deposits of Alzheimer's disease. Cell 1988 52 487–501.
  • Snow AD, Mar H, Nochlin D, Kimata K, Kato M, Suzuki S, Hassell J, Wight TN The presence of heparan sulphate proteoglycans in the neuritic plaques and congophilic angiopathy in Alzheimer's disease. Am. J. Pathol. 1988 133 456–63.
  • Rosenblatt DE, Geula C, Mesulam MM Protease nexin I immunostaining in Alzheimer's disease. Ann. Neurol. 1989 26 628–634.
  • Mesulam M-M, Geula C, Moran MA Anatomy of cholinesterase inhibition in Alzheimer's disease: Effect of physostigmine and tetrahydroaminoacridine on plaques and tangles. Ann. Neurol. 1987 22 683–91.
  • Masters CL, Multhaup G, Simms G, Pottgiesser J, Martins RN, Beyreuther K Neuronal origin of a cerebral amyloid: Neurofibrillary tangles of Alzheimer's disease contain the same protein as the amyloid of plaque cores and blood vessels. EMBO J. 1985 4 2757–2763.
  • Brion JP Molecular pathology of Alzheimer amyloid and neurofibrillary tangles. Seminars in the Neurosciences 1990 102 89–100.
  • Flament S, Delacourte A, Hemon B, Defossez A Characterisation of two pathological Tau protein variants in Alzheimer brain cortices. J. Neurol. Sci. 1989 92 133–41.
  • Tanzi RE, St. George-Hyslop P, Gusella JF Molecular genetics of Alzheimer's disease amyloid. J. Biol. Chem. 1991 266 20579–20582.
  • Goldgaber D, Lerman MI, McBride OW, Saffioti U, Gajdusek DC Characterisation and chromosomal localisation of a cDNA encoding brain amyloid of Alzheimer's disease. Science 1987 235 877–880.
  • Ponte P, Gonzalez-DeWhitt P, Shilling J, Miller J, Hsu D, Greenberg B, Davis K, Wallace W, Lieberburg L, Fuller F, Cordell B A new A4 amyloid mRNA contains a domain homologous to serine proteinase inhibitors. Nature 1988 331 525–527.
  • Johnson SA, McNeill T, Cordell B, Finch CE Relation of neuronal APP-751/APP-695 mRNA ratio and neuritic plaque density in Alzheimer's disease. Science 1990 248 854–857.
  • Martin LJ, Sisodia SS, Koo EH, Cork LC, Dellovade TL, Weidemann A, Beyreuther K, Masters CL, Price DL Amyloid precursor protein in aged non-human primates. Proc. Natl. Acad. Sci. USA 1991 88 1461–1465.
  • Arai H, Lee VMY, Otvos I, Greenberg BD, Lowery DE, Sharma SK, Schmidt ML, Trojanowski JQ Precursor protein epitopes distinguish Alzheimer from non-Alzheimer senile plaques. Proc. Natl. Acad. Sci. USA 1990 87 2249–2253.
  • Koo EH, Sisodia SS, Archer DR, Martin LJ, Weidemann A, Beyreuther K, Fischer P, Masters CL, Price DL Precursor of amyloid protein in Alzheimer's disease undergoes fast axonal transport. Proc. Natl. Acad. Sci. USA 1990 87 1561–1565.
  • Gandy S, Greengard P Amyloidogenesis in Alzheimer's disease: Some possible therapeutic opportunities. Trends Pharmacol. Sci. 1992 13 108–113.
  • Buxbaum JD, Gandy SE, Cicchetti P, Ehrlich ME, Czernik AJ, Fracasso RP, Ramabhadran TV, Unterbeck AJ, Greengard P Processing of Alzheimer beta-A4 amyloid precursor protein-modulation by agents that regulate protein phosphorylation. Proc. Natl. Acad. Sci. USA 1990 87 6003–6006.
  • Roher AE, Ball MJ, Bhave SV, Wakade AR β-amyloid from Alzheimer disease brains inhibits sprouting and survival of sympathetic neurons. Biochem. Biophys. Res. Commun. 1991 174 572–579.
  • Yanker BA, Duffy LK, Krischner DA Neurotrophic and neurotoxic effects of amyloid β protein: Reversal by tachykinin neuropeptides. Science 1990 250 279–282.
  • Koh Y-Y, Yang LI, Cotman CW β-amyloid protein increases the vulnerability of the cultured cortical neurons to excitotoxic damage. Brain Res. 1991 533 315–20.
  • Mattson MP, Cheng B, Davis D, Bryant K, Lieberburg I, Rydel R β-amyloid peptides destabilise calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J. Neurosc. 1992 12 376–89.
  • Maruyama K, Terakado K, Usami M, Yoshikawa K Formation of amyloid-like fibrils in COS cells overexpressing part of the Alzheimer amyloid protein precursor. Nature 1990 347 566–69.
  • Hardy JA, Mullan M, Chartier-Harlin M-C, Brown J, Goate A, Rossor M, Collinge J, Roberts G, Luthert P, Lantos P, Naruse S, Kaneko K, Tsuji T, Miyatake T, Shimizo T, Kojima T, Nakano I, Yoshioka K, Sakaki Y, Miki T, Katsuya T, Ogihara T, Roses A, Pericak-Vance M, Haan J, Roos R, Lucotte G, David F Molecular classification of Alzheimer's disease. Lancet 1991 337 1342–1343.
  • Goate A, Chartier-Harlin A-M, Mullan M, Brown J, Crawford F, Fidani L, Giuffra L, Haynes A, Irving N, James L, Mant R, Newton P, Rooke K, Roques P, Talbot C, Pericak-Vance M, Roses A, Williamson R, Rossor M, Owen M, Hardy J Segregation of a missence mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 1991 349 704–706.
  • Charter-Harlin M-C, Crawford F, Hamandi K, Mullan M, Goate A, Hardy J, Backhovens H, Martin J-J, Van Broeckhoven C Screening for the B-amyloid precursor protein mutation (APP717: Val→Ile) in extended pedigrees with early onset Alzheimer's disease. Neurosci. Lett. 1991 129 134–135.
  • Naruse S, Igarashi S, Aoki K, Kaneko K, Ihara K, Miyatake T, Kobayashi H, Inuzuka T, Shimizu T, Kojima T, Tsuji S Missense mutation Val-Ile in exon 17 of amyloid precursor protein gene in Japanese families. Lancet 1991 337 979.
  • Levy E, Carman MD, Fernandez-Madrid IJ, Power MD, Lieberburg I, Van Duinen SG, Bots GTA, Luyendijk W, Frangione B Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. Science 1990 248 1124–1126.
  • Ishiura S Proteolytic cleavage of the Alzheimer's disease amyloid A4 precursor protein. J. Neurochem. 1991 56 363–369.
  • Selkoe DJ The molecular pathology of Alzheimer's disease. Neuron. 1991 6 487–498.
  • Sisodia SS, Koo EH, Beyreuther K, Unterbeck A, Price DL Evidence that B-amyloid protein in Alzheimer's disease is not derived by normal processing. Science 1990 248 492–495.
  • Esch FS, Keim PS, Beattie EC, Blacher RW, Culwell AR, Oltersdorf T, McClure D, Ward PJ Cleavage of amyloid β peptide during constitutive processing of its precursor. Science 1990 248 1122–1124.
  • Estus S, Golde TE, Kunishita T, Blades D, Lowery D, Eisen M, Usiak M, Qu X, Tabira T, Greenberg BD, Younkin SG Potentially amyloidogenic carboxyl-terminal derivatives of the amyloid protein precursor. Science 1992 225 726–728.
  • Gandy SE, Bhasin R, Ramabhadran TV, Koo EH, Price DL, Goldgaber D, Greengard P Alzheimer B/A4-amyloid precursor protein: Evidence for putative amyloidogenic fragment. J. Neurochem. 1992 58 383–386.
  • Levy E, Frangione B Familial Alzheimer's disease. Curr. Biol. 1991 1 312–314.
  • Tamaoka A, Selkoe DJ Identification of a stable fragment of the Alzheimer amyloid precursor containing the intact β-protein in brain microvessels. Neurology 1991 41 Suppl 1 157.
  • Golde TE, Estus S, Younkin LH, Selkoe DJ, Younkin SG Processing of the amyloid protein precursor to potentially amyloidogenic derivaties. Science 1992 225 728–730.
  • Prior R, Monning U, Schreiter-Gasser U, Weidemann A, Blennow K, Gottfries CG, Masters CL, Beyreuther K Quantitative changes in the amyloid BA4 precursor protein in Alzheimer cerebrospinal fluid. Neurosci. Lett. 1991 124 69–73.
  • Henrikson T, Barbour RM, Braa S, Ward P, Fritz LC, Wood Johnson K, Chung HD, Burke W, Reinikainen KJ, Riekkinen P, Schenk DB Analysis and quantification of the β-amyloid precursor protein in the cerebrospinal fluid of Alzheimer's disease patients with a monoclonal antibody-based immunoassay. J. Neurochem. 1991 56 1037–42.
  • Kitaguchi N, Tokushima Y, Oishi K, Takahashi Y, Shiojiri S, Nakamura S, Tanaka S, Kodaira R, Ito H Determination of amyloid βprotein precursors harbouring active forms of proteinase inhibitor domains in cerebrospinal fluid of Alzheimer's disease patients by trypsin-antibody sandwich ELISA. Biochem. Biophys. Res. Commun. 1990 166 1453–59.
  • Palmert MR, Usiak M, Mayeux R, Rashial M, Tourtellotte WW, Younkin SG Soluble derivatives of the β-amyloid protein precursor in cerebrospinal fluid. Neurology 1990 40 1028–34.
  • Cole GM, Galasko D, Shapiro IP, Saitoh T Stimulated platelets release amyloid β-protein precursor. Biochem. Biophys. Res. Commun. 1990 170 288–295.
  • Gardella JE, Ghiso J, Gorgone GA, Marratta D, Kaplan AP, Frangione B, Gorevic PD Intact Alzheimer amyloid precursor protein (APP) is present in platelet membranes and is encoded by platelet mRNA. Biochem. Biophys. Res. Commun. 1990 173 1292–1298.
  • Bush AI, Martins RN, Rumble B, Moir R, Fuller S, Milward E, Currie J, Ames D, Weidemann A, Fischer P, Multhaup G, Beyreuther K, Masters CL The amyloid precursor protein of Alzheimer's disease is released by human platelets. J. Biol. Chem. 1990 265 15977–15983.
  • Alder MJ, Coronel C, Shelton E, Seegmiller JE, Dewji NN Increased gene expression of Alzheimer disease B-amyloid precursor protein in senescent cultured fibroblasts. Proc. Natl. Acad. Sci. USA 1991 88 16–20.
  • Kawai M, Kalaria RN, Harik SI, Perry G The relationship of amyloid plaques to cerebral capillaries in Alzheimer's disease. Am. J. Pathol. 1990 137 1435–1446.
  • Van Nostrand WE, Schmaier AH, Farrow JS, Cunningham DD Protease Nexin-II (amyloid β protein precursor): A platelet α-granule protein. Science 1990 248 745–748.
  • Zubenko GS, Cohen BM, Boller F, Malinakova I, Keefe N, Chojnacki B Platelet membrane abnormality in Alzheimer's disease. Ann. Neurol. 1987 22 237–244.
  • Hicks N, Brammer MJ, Hymas N, Levy R Platelet membrane properties in Alzheimer and multi-infarct dementias. Alzheimer Disease and Associated Disorders 1987 1 90–97.
  • Hajimohammadreza I, Brammer MJ, Eagger S, Burns A, Levy R Platelet and erythrocyte membrane changes in Alzheimer's disease. Biochem. Biophys. Acta. 1990 1025 208–214.
  • Farrar G, Altman P, Welch S, Wychrij O, Ghose B, Lejeune J, Corbett J, Prasher V, Blair JA Defective gallium-transferrin binding in Alzheimer and Down syndrome: Possible mechanism for accumulation of aluminium in brain. Lancet 1990 335 747–750.

References to Patent Literature

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.